4Q16 worldwide Botox sales—$739M, +14% YoY, +7% QoQ* in local currency: http://phx.corporate-ir.net/External.File?t=1&item=VHlwZT0yfFBhcmVudElEPTUyNDYzNjh8Q2hpbGRJRD02NTk2NTQ= 72% of Botox sales were in the US, where the therapeutic/cosmetic split was 60/40. 28% of Botox sales were ex-US, where the therapeutic/cosmetic split was 40/60. *For cosmetic indications, the second and fourth quarters are seasonally stronger than the first and third quarters .